Department of Dermatology and Dermatologic Surgery, University of Texas at Austin Dell Medical School, Austin, TX, USA.
Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.
Pediatr Dermatol. 2021 Nov;38(6):1529-1531. doi: 10.1111/pde.14835. Epub 2021 Oct 29.
Intravenous immunoglobulin (IVIg) is a frequently used treatment modality in the pediatric inpatient population for acute diseases such as Kawasaki disease and Stevens-Johnson syndrome. There are few reported cutaneous adverse events after IVIg in the pediatric population. Here, we present two patients with psoriasiform dermatitis appearing after IVIg treatment for two different disease processes, Kawasaki disease and mycoplasma-associated mucositis, suggesting an association with the treatment instead of the disease process.
静脉注射免疫球蛋白 (IVIg) 是儿科住院患者中用于治疗急性疾病（如川崎病和 Stevens-Johnson 综合征）的常用治疗方法。在儿科人群中，IVIg 后很少有报道出现皮肤不良反应。在这里，我们介绍了两名患者在因两种不同疾病过程（川崎病和支原体相关性黏膜炎）接受 IVIg 治疗后出现银屑病样皮炎，提示与治疗相关，而与疾病过程无关。
